Brief: Poolbeg Pharma Says Further Data Showed Polb001's Potential In Cancer CRS
17/01/2024 07:52
Jan 17 (Reuters) - Poolbeg Pharma PLC POLB.L :
* POOLBEG PHARMA PLC - FURTHER DATA SHOWS POLB001 POTENTIAL
IN
CANCER CRS
Source text for Eikon: ID:nRSQ9157Za
Further company coverage: POLB.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
PDMR Notification
Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice